Category: Crypto News, News
XRP Price Eyes $5.16 Target as Bulls Fight to Hold Key Support
XRP holds steady at crucial $2.83 Fibonacci level, setting up potential rally toward $5.16 if bulls can maintain control.
XRP (XRP) Price Battles at Critical $2.83 Support Zone
XRP is trading at $2.86, down 3.36% today, but it’s holding onto something important – the 0.382 Fibonacci retracement level around $2.83. This isn’t just any random number; traders have been watching this zone like hawks because it could make or break XRP’s next big move.
The price dipped to $2.81 earlier but bounced back, showing there’s still some fight left in the bulls. That quick recovery above $2.83 has caught analysts’ attention, especially since this level has been acting as a major decision point for weeks.
LeandroCrypto recently posted on X about this exact setup, calling it XRP’s moment of truth. The chart he shared shows how this Fibonacci level could be the springboard for something much bigger – potentially pushing XRP all the way to $5.16.
XRP (XRP) Price Could Double if Bulls Stay Strong
Here’s where things get interesting. If XRP can stay above that $2.83 sweet spot, we’re looking at a possible run to $5.16 – that’s nearly double from where it sits now. The technical setup looks pretty solid too, with an ascending trendline providing backup support and trading volume holding steady at 102.29M.

- Current spot: $2.86
- Make-or-break support: $2.83
- First trouble zone: $2.62
- Deeper support: $2.43
- Moon target: $5.16
Right now, it’s all about whether buyers can keep XRP above that $2.83 line in the sand. If they can’t, we might see a slide toward $2.62 or even lower. But if they hold strong, XRP could be gearing up for its next big rally.
The volume and price action suggest traders are positioning for a breakout. Whether that happens in the next few days or weeks depends on how well the bulls can defend this crucial Fibonacci zone.
Written by : Editorial team of BIPNs
Main team of content of bipns.com. Any type of content should be approved by us.
Share this article: